Skip to main content
Top
Published in: Molecular Neurodegeneration 1/2007

Open Access 01-12-2007 | Research article

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

Authors: Rakez Kayed, Elizabeth Head, Floyd Sarsoza, Tommy Saing, Carl W Cotman, Mihaela Necula, Lawrence Margol, Jessica Wu, Leonid Breydo, Jennifer L Thompson, Suhail Rasool, Tatyana Gurlo, Peter Butler, Charles G Glabe

Published in: Molecular Neurodegeneration | Issue 1/2007

Login to get access

Abstract

Background

Amyloid-related degenerative diseases are associated with the accumulation of misfolded proteins as amyloid fibrils in tissue. In Alzheimer disease (AD), amyloid accumulates in several distinct types of insoluble plaque deposits, intracellular Aβ and as soluble oligomers and the relationships between these deposits and their pathological significance remains unclear. Conformation dependent antibodies have been reported that specifically recognize distinct assembly states of amyloids, including prefibrillar oligomers and fibrils.

Results

We immunized rabbits with a morphologically homogeneous population of Aβ42 fibrils. The resulting immune serum (OC) specifically recognizes fibrils, but not random coil monomer or prefibrillar oligomers, indicating fibrils display a distinct conformation dependent epitope that is absent in prefibrillar oligomers. The fibril epitope is also displayed by fibrils of other types of amyloids, indicating that the epitope is a generic feature of the polypeptide backbone. The fibril specific antibody also recognizes 100,000 × G soluble fibrillar oligomers ranging in size from dimer to greater than 250 kDa on western blots. The fibrillar oligomers recognized by OC are immunologically distinct from prefibrillar oligomers recognized by A11, even though their sizes overlap broadly, indicating that size is not a reliable indicator of oligomer conformation. The immune response to prefibrillar oligomers and fibrils is not sequence specific and antisera of the same specificity are produced in response to immunization with islet amyloid polypeptide prefibrillar oligomer mimics and fibrils. The fibril specific antibodies stain all types of amyloid deposits in human AD brain. Diffuse amyloid deposits stain intensely with anti-fibril antibody although they are thioflavin S negative, suggesting that they are indeed fibrillar in conformation. OC also stains islet amyloid deposits in transgenic mouse models of type II diabetes, demonstrating its generic specificity for amyloid fibrils.

Conclusion

Since the fibril specific antibodies are conformation dependent, sequence-independent, and recognize epitopes that are distinct from those present in prefibrillar oligomers, they may have broad utility for detecting and characterizing the accumulation of amyloid fibrils and fibrillar type oligomers in degenerative diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wisniewski HM, Terry RD: Reexamination of the pathogenesis of the senile plaque. Prog Neuropathol. 1973, 333 , 2: 1-26. Wisniewski HM, Terry RD: Reexamination of the pathogenesis of the senile plaque. Prog Neuropathol. 1973, 333 , 2: 1-26.
2.
go back to reference Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH: Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol. 1988, 163 , 132: 86-101. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH: Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol. 1988, 163 , 132: 86-101.
3.
go back to reference Verkkoniemi A, Somer M, Rinne JO, Myllykangas L, Crook R, Hardy J, Viitanen M, Kalimo H, Haltia M: Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology. 2000, 54 (5): 1103-1109.CrossRefPubMed Verkkoniemi A, Somer M, Rinne JO, Myllykangas L, Crook R, Hardy J, Viitanen M, Kalimo H, Haltia M: Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology. 2000, 54 (5): 1103-1109.CrossRefPubMed
4.
go back to reference Yang AJ, Knauer M, Burdick DA, Glabe C: Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J Biol Chem. 1995, 270 (24): 14786-14792. 10.1074/jbc.270.24.14786.CrossRefPubMed Yang AJ, Knauer M, Burdick DA, Glabe C: Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J Biol Chem. 1995, 270 (24): 14786-14792. 10.1074/jbc.270.24.14786.CrossRefPubMed
5.
go back to reference Martin BL, Schrader-Fischer G, Busciglio J, Duke M, Paganetti PYBA: Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J Biol Chem. 1995, 2366 , 270: 26727-26730. 10.1074/jbc.270.45.26727. Martin BL, Schrader-Fischer G, Busciglio J, Duke M, Paganetti PYBA: Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J Biol Chem. 1995, 2366 , 270: 26727-26730. 10.1074/jbc.270.45.26727.
6.
go back to reference Skovronsky DM, Doms RW, Lee VM: Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J Cell Biol. 1998, 141 (4): 1031-1039. 10.1083/jcb.141.4.1031.PubMedCentralCrossRefPubMed Skovronsky DM, Doms RW, Lee VM: Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J Cell Biol. 1998, 141 (4): 1031-1039. 10.1083/jcb.141.4.1031.PubMedCentralCrossRefPubMed
7.
go back to reference D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH: Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 2001, 38 (2): 120-134. 10.1046/j.1365-2559.2001.01082.x.CrossRefPubMed D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH: Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 2001, 38 (2): 120-134. 10.1046/j.1365-2559.2001.01082.x.CrossRefPubMed
8.
go back to reference Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR: Intraneuronal Abeta42 accumulation in human brain. Am J Pathol. 2000, 156 (1): 15-20.PubMedCentralCrossRefPubMed Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR: Intraneuronal Abeta42 accumulation in human brain. Am J Pathol. 2000, 156 (1): 15-20.PubMedCentralCrossRefPubMed
9.
10.
go back to reference Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS: Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol. 1981, 10 (2): 184-192. 10.1002/ana.410100209.CrossRefPubMed Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS: Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol. 1981, 10 (2): 184-192. 10.1002/ana.410100209.CrossRefPubMed
11.
go back to reference Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J: Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol. 1999, 155 (3): 853-862.PubMedCentralCrossRefPubMed Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J: Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol. 1999, 155 (3): 853-862.PubMedCentralCrossRefPubMed
12.
go back to reference McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL: Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol. 1999, 46 (6): 860-866. 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M.CrossRefPubMed McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL: Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol. 1999, 46 (6): 860-866. 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M.CrossRefPubMed
13.
go back to reference Haass C, Selkoe DJ: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007, 8 (2): 101-112. 10.1038/nrm2101.CrossRefPubMed Haass C, Selkoe DJ: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007, 8 (2): 101-112. 10.1038/nrm2101.CrossRefPubMed
14.
go back to reference Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994, 1681 , 13: 45-53. 10.1016/0896-6273(94)90458-8. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 1994, 1681 , 13: 45-53. 10.1016/0896-6273(94)90458-8.
15.
go back to reference Fukumoto H, Asami-Odaka A, Suzuki N, Iwatsubo T: Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration. 1996, 5 (1): 13-17. 10.1006/neur.1996.0002.CrossRefPubMed Fukumoto H, Asami-Odaka A, Suzuki N, Iwatsubo T: Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration. 1996, 5 (1): 13-17. 10.1006/neur.1996.0002.CrossRefPubMed
16.
go back to reference Hrncic R, Wall J, Wolfenbarger DA, Murphy CL, Schell M, Weiss DT, Solomon A: Antibody-mediated resolution of light chain-associated amyloid deposits. Am J Pathol. 2000, 157 (4): 1239-1246.PubMedCentralCrossRefPubMed Hrncic R, Wall J, Wolfenbarger DA, Murphy CL, Schell M, Weiss DT, Solomon A: Antibody-mediated resolution of light chain-associated amyloid deposits. Am J Pathol. 2000, 157 (4): 1239-1246.PubMedCentralCrossRefPubMed
17.
go back to reference O'Nuallain B, Wetzel R: Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A. 2002, 99 (3): 1485-1490. 10.1073/pnas.022662599.PubMedCentralCrossRefPubMed O'Nuallain B, Wetzel R: Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A. 2002, 99 (3): 1485-1490. 10.1073/pnas.022662599.PubMedCentralCrossRefPubMed
18.
go back to reference Williams AD, Sega M, Chen M, Kheterpal I, Geva M, Berthelier V, Kaleta DT, Cook KD, Wetzel R: Structural properties of Abeta protofibrils stabilized by a small molecule. Proc Natl Acad Sci U S A. 2005, 102 (20): 7115-7120. 10.1073/pnas.0408582102.PubMedCentralCrossRefPubMed Williams AD, Sega M, Chen M, Kheterpal I, Geva M, Berthelier V, Kaleta DT, Cook KD, Wetzel R: Structural properties of Abeta protofibrils stabilized by a small molecule. Proc Natl Acad Sci U S A. 2005, 102 (20): 7115-7120. 10.1073/pnas.0408582102.PubMedCentralCrossRefPubMed
19.
go back to reference Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003, 300 (5618): 486-489. 10.1126/science.1079469.CrossRefPubMed Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003, 300 (5618): 486-489. 10.1126/science.1079469.CrossRefPubMed
20.
go back to reference Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, Chiti F, Dobson CM, Stefani M: Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci. 2006, 26 (31): 8160-8167. 10.1523/JNEUROSCI.4809-05.2006.CrossRefPubMed Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, Chiti F, Dobson CM, Stefani M: Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci. 2006, 26 (31): 8160-8167. 10.1523/JNEUROSCI.4809-05.2006.CrossRefPubMed
21.
go back to reference Harper JD, Wong SS, Lieber CM, Lansbury PT: Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol. 1997, 4 (2): 119-125. 10.1016/S1074-5521(97)90255-6.CrossRefPubMed Harper JD, Wong SS, Lieber CM, Lansbury PT: Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol. 1997, 4 (2): 119-125. 10.1016/S1074-5521(97)90255-6.CrossRefPubMed
22.
go back to reference Necula M, Kayed R, Milton S, Glabe CG: Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem. 2007, 282 (14): 10311-10324. 10.1074/jbc.M608207200.CrossRefPubMed Necula M, Kayed R, Milton S, Glabe CG: Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem. 2007, 282 (14): 10311-10324. 10.1074/jbc.M608207200.CrossRefPubMed
23.
go back to reference Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL: Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Nat Acad Sci USA. 1998, 95 (11): 6448-6453. 10.1073/pnas.95.11.6448.PubMedCentralCrossRefPubMed Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL: Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Nat Acad Sci USA. 1998, 95 (11): 6448-6453. 10.1073/pnas.95.11.6448.PubMedCentralCrossRefPubMed
24.
go back to reference von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E: Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Nat Acad Sci USA. 2000, 97 (10): 5129-5134. 10.1073/pnas.97.10.5129.PubMedCentralCrossRefPubMed von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E: Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Nat Acad Sci USA. 2000, 97 (10): 5129-5134. 10.1073/pnas.97.10.5129.PubMedCentralCrossRefPubMed
25.
go back to reference Lin CY, Gurlo T, Kayed R, Butler AE, Haataja L, Glabe CG, Butler PC: Toxic Human IAPP Oligomers are Intracellular, and Vaccination to Induce Anti-toxic Oligomer Antibodies Does not Prevent Human IAPP Induced Beta-Cell Apoptosis in Human IAPP Transgenic Mice. Diabetes. 2007 Lin CY, Gurlo T, Kayed R, Butler AE, Haataja L, Glabe CG, Butler PC: Toxic Human IAPP Oligomers are Intracellular, and Vaccination to Induce Anti-toxic Oligomer Antibodies Does not Prevent Human IAPP Induced Beta-Cell Apoptosis in Human IAPP Transgenic Mice. Diabetes. 2007
26.
go back to reference Chen YR, Glabe CG: Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J Biol Chem. 2006, 281 (34): 24414-24422. 10.1074/jbc.M602363200.CrossRefPubMed Chen YR, Glabe CG: Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J Biol Chem. 2006, 281 (34): 24414-24422. 10.1074/jbc.M602363200.CrossRefPubMed
27.
go back to reference Kayed R, Glabe CG: Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol. 2006, 413: 326-344.CrossRefPubMed Kayed R, Glabe CG: Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol. 2006, 413: 326-344.CrossRefPubMed
28.
go back to reference Butler AE, Janson J, Soeller WC, Butler PC: Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes. 2003, 52 (9): 2304-2314. 10.2337/diabetes.52.9.2304.CrossRefPubMed Butler AE, Janson J, Soeller WC, Butler PC: Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes. 2003, 52 (9): 2304-2314. 10.2337/diabetes.52.9.2304.CrossRefPubMed
29.
go back to reference Wang B: Simultaneous demonstration of multiple antigens by indirect immunofluorescence or immunogold staining. Histochemistry. 1985, 83: 47-56. 10.1007/BF00495299.CrossRefPubMed Wang B: Simultaneous demonstration of multiple antigens by indirect immunofluorescence or immunogold staining. Histochemistry. 1985, 83: 47-56. 10.1007/BF00495299.CrossRefPubMed
Metadata
Title
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
Authors
Rakez Kayed
Elizabeth Head
Floyd Sarsoza
Tommy Saing
Carl W Cotman
Mihaela Necula
Lawrence Margol
Jessica Wu
Leonid Breydo
Jennifer L Thompson
Suhail Rasool
Tatyana Gurlo
Peter Butler
Charles G Glabe
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2007
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/1750-1326-2-18

Other articles of this Issue 1/2007

Molecular Neurodegeneration 1/2007 Go to the issue